Prescribing guidance

This guidance is intended to provide managers, responsible individuals, registered nurses and care support workers in Welsh organisations with information on how and when a registered nurse may delegate the task of medicines support to a care support worker, and the necessary education and training standards, and policies and procedures that are required to facilitate this.

This document is intended for non-specialist practitioners engaged in the prescribing and monitoring of medical therapies used in the management of gender dysphoria.

The All Wales Guide to Prescribing Gluten-free Products aims to support general practitioners and other healthcare professionals in the management of patients with coeliac disease, and aid the decision-making process in relation to prescribing Advisory Committee on Borderline Substances (ACBS)-approved gluten-free foods.

This document aims to highlight and help address the patient safety issues associated with the long-term use of proton pump inhibitors (PPIs) in adults.

This guide supports the appropriate prescribing and supply of smoking cessation pharmacotherapy in NHS Wales for smokers who are motivated to quit.

The Common Ailments service aims to improve patient access to consistent, evidence-based advice for the management of common ailments. The formulary was developed using recognised resources and involved multi-professional consultation to ensure the provision of consistent advice by pharmacists and GPs.

This policy document has been developed to provide healthcare professionals with information to promote the safe and timely completion of medicines reconciliation and provides guidance on completing the process.

This CKD medicines management resource includes supporting information for primary care teams around clinical issues, signposts to further useful resources and contains an educational slide set.

This guidance aims to provide healthcare professionals with information to better inform patients on how to manage dry eye syndrome using good eyelid hygiene.

The purpose of this guidance is to raise awareness of the recommendations on routine vitamin supplementation for babies, children, and pregnant and breastfeeding women, including vitamin D.

This document aims to ensure that all patients receive appropriate anticoagulation in a timely manner and to address prescribers’ concerns relating to the safe prescribing of LMWH.

Primary and secondary care clinicians have recognised that it would be beneficial to review all patients taking amiodarone in Wales to establish the need for ongoing treatment. The enclosed documentation has been developed to assist this process.

The purpose of the policy is to set out the minimum standards of practice that must be adopted by all healthcare employees involved in the administration, recording, review, storage and disposal of medicines in Welsh hospitals.

This document aims to provide guidance regarding the timing and type of antimicrobial prophylaxis that should be offered to women undergoing Caesarean Section in Wales.

This document outlines an All Wales strategy to modify the risks associated with longer-term use of bisphosphonate treatment, via reassessment of patients and consideration of ‘drug holidays’.

This Handbook for Homecare Services in Wales has been adapted from the Handbook for Homecare Services in England, which was published by the Royal Pharmaceutical Society (RPS) in May 2014.

This document is a review of the 2011 guidance and provides recommendations and guidance relating to the prescribing in Wales of denosumab (Prolia) for the prevention of osteoporotic fractures in postmenopausal women, and is intended to complement NICE TA204.

This protocol has been produced by Aneurin Bevan Health Board. It is used to facilitate the self administration of intranasal fentanyl preparations for patients admitted to non-specialist palliative in-patient settings within Aneurin Bevan Health Board.